SEC Filings

8-K
PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 02/19/2019
Entire Document
 

 

Positive Product Working Capital 1.1
Positive Product Working Capital Credit Bid Consideration 1.1
Post-Closing Tax Period 6.4
Pre-Auction Designation Date 2.6(d)
Pre-Closing Statement 2.8
Pre-Closing Tax Period 6.4
Prepetition DDTL Agreement 1.1
Prepetition DDTL Loan Documents 1.1
Prepetition DDTL Obligations 1.1
Product Approvals 1.1
Product Intellectual Property 1.1
Product Marketing Materials 1.1
Product Regulatory Materials 1.1
Product Working Capital Assets 1.1
Product Working Capital Liabilities 1.1
Products 1.1
Purchase Price 2.7(a)
Purchase Price Allocation 2.10
Qualified Bidder 1.1
Qualified Leave Recipient 1.1
Real Property 1.1
Reference Statement 1.1
Regulatory Approvals 1.1
Release 1.1
Representatives 1.1
Sale Hearing 1.1
Sale Motion 5.8(a)
Sale Order 1.1
Sale Procedures 1.1
Sale Procedures Order 1.1
SEC 3.5(a)
Securities Act 3.5(a)
Seller Preamble
Seller Financial Statements 3.5(c)
Seller Parent Preamble
Seller Taxes 1.1
Seller Unaudited Financial Statements 3.5(c)
Seller-Paid Buyer Taxes 2.7(a)
Sellers Preamble
Sellers Plans 5.4(j)
Sensitive Data 1.1
Services Agreement 1.1
Shared GTN Contracts 1.1
Software 1.1
Specified Cure Claims 1.1
Specified DIP Credit Bid Consideration 1.1

   

 

26